New cancer clinical trial: Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

Published on: January 26, 2018 at 12:00PM
Conditions:   Breast Cancer;   HER2 Gene Mutation
Intervention:   Drug: Pyrotinib
Sponsor:   Peking Union Medical College
Recruiting
http://ift.tt/2Gmv7A8